Edvince
Lund
About Edvince
Edvince is a biotechnology company that develops a new treatment that has great potential to minimize brain damage in a stroke. The treatment is based on Professor Lars Edvinsson's long-term research.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.9M
- Last round: Grant (Oct 2021)
- Website: edvince.com
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/edvince-96465 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.